Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Timeline

Oyster Therapeutics

British protein-degrader biotech targeting tau in Alzheimer's; formerly Kesmalea, raised $60m in 2026.

1 of 1 entries (1 events, 0 interactions)

Filters
#17 10 Nov

Closed a $60m Series A

UK Startups and Innovation: Oyster brings Eli Lilly into $60m round